No Data
No Data
No Data
No Data
No Data
China Post Securities: Endogenous growth is steady, and the Hong Kong stock healthcare services sector's valuation is highly attractive
Judging from the overall performance of medical service targets in Hong Kong stocks, with the exception of ICL's high revenue base in the early COVID-19 period, where dental revenue was affected by dental implant collection, most of the revenue from other medical service targets increased relatively well.
Zhitong FinanceApr 12 03:07 ET
Kanghua Healthcare (03689) announces 2023 annual results. Profit attributable to shareholders of 121 million yuan increased by 102.8% year-on-year
Kanghua Healthcare (03689) announced its annual results for the year ended December 31, 2023. The group made profits during the period...
Zhitong FinanceMar 28 12:40 ET
KANGHUA HEALTH: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2023
Futu NewsMar 28 09:56 ET · Announcements
Kanghua Healthcare (03689.HK) held a board meeting on March 28 to consider and approve the annual results
Glonghui, March 18, 丨 Kanghua Healthcare (03689.HK) announced that the company will hold a board meeting on March 28, 2024 (Thursday) to consider and approve the annual results and announcements of the company and its subsidiaries for the year ended 31 December 2023, and to consider the proposed payment of a final dividend (if any).
Gelonghui FinanceMar 18 04:51 ET
Guangdong Kanghua Healthcare Acquires Haemodialysis Operating Company for 7.7 Million Yuan
Guangdong Kanghua Healthcare (HKG:3689) agreed to acquire 70% of Dongguan Kanghua Haemodialysis Healthcare Investment Management from Dongguan YouWang Enterprise Investment for a consideration of 7.7
MT NewswiresDec 15, 2023 05:55 ET
Kanghua Medical (03689.HK): Plans to acquire 70% of Dongguan Kanghua Hemodialysis Healthcare Investment Management's shares for 7.7 million yuan
On December 15, Gelonghui (03689.HK) announced that on December 15, 2023, the company signed an acquisition agreement. According to this, the company has agreed to acquire 70% of the shares of the target company Dongguan Kanghua Hemodialysis Medical Investment Management Co., Ltd. from the seller at a total cost of RMB 7.7 million. The target company, through its subsidiaries, mainly operates hemodialysis clinic centers in China. Upon completion, the target company will become a non-wholly owned subsidiary of the company. According to reports, the target company is a limited liability company established in China on February 24, 2016. The target company mainly through its subsidiaries
Gelonghui FinanceDec 15, 2023 04:47 ET
No Data
No Data